| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72bd1e19777006411d683035a3fc7a9c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
| filingDate |
2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f6c03cc27263e4daf9808325f4d884b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6ca6bbbf8b146d45a6bac01ae47c5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f104ffd67f8c70b793dc81058033d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edad4f37da61af532e84bc15f10fc57e |
| publicationDate |
2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022026902-A2 |
| titleOfInvention |
Chimeric proteins and methods of use for treatment of central nervous system disorders |
| abstract |
Aspects of the present disclosure relate generally to kits and methods for treating acute central nervous systems disorders with chimeric proteins and pharmaceutical compositions comprising such chimeric proteins. |
| priorityDate |
2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |